LIVZON PHARMA Receives Vietnamese Regulatory Approval for IMP Share Tender Offer

Stock News03-06

LIVZON PHARMA (01513) has announced that its overseas wholly-owned subsidiary, LIANSGP HOLDING PTE. LTD. (LIANSGP), has formally received approval documents from the Vietnamese State Securities Commission for its proposed public tender offer to acquire shares in IMP. The company's board of directors had previously approved the proposal to acquire equity in the Vietnamese company IMP and to launch a public tender offer for its shares during meetings held on May 22, 2025, and December 30, 2025. Following these board resolutions, LIANSGP submitted the relevant application for the tender offer to the Vietnamese regulatory authority. The company stated it will actively advance the matters related to this transaction.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1173968783?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-06 18:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1173968783","market":"sg","top_or_hot":-1,"title":"LIVZON PHARMA Receives Vietnamese Regulatory Approval for IMP Share Tender Offer","media":"Stock News","content":"<p>LIVZON PHARMA (01513) has announced that its overseas wholly-owned subsidiary, LIANSGP HOLDING PTE. LTD. (LIANSGP), has formally received approval documents from the Vietnamese State Securities Commission for its proposed public tender offer to acquire shares in IMP. The company's board of directors had previously approved the proposal to acquire equity in the Vietnamese company IMP and to launch a public tender offer for its shares during meetings held on May 22, 2025, and December 30, 2025. Following these board resolutions, LIANSGP submitted the relevant application for the tender offer to the Vietnamese regulatory authority. The company stated it will actively advance the matters related to this transaction.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>LIVZON PHARMA Receives Vietnamese Regulatory Approval for IMP Share Tender Offer</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLIVZON PHARMA Receives Vietnamese Regulatory Approval for IMP Share Tender Offer\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-03-06 18:58</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>LIVZON PHARMA (01513) has announced that its overseas wholly-owned subsidiary, LIANSGP HOLDING PTE. LTD. (LIANSGP), has formally received approval documents from the Vietnamese State Securities Commission for its proposed public tender offer to acquire shares in IMP. The company's board of directors had previously approved the proposal to acquire equity in the Vietnamese company IMP and to launch a public tender offer for its shares during meetings held on May 22, 2025, and December 30, 2025. Following these board resolutions, LIANSGP submitted the relevant application for the tender offer to the Vietnamese regulatory authority. The company stated it will actively advance the matters related to this transaction.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"FT_SY_FVN","symbol_name":"富时越南30指数","start_time":0,"source_url":"","article_id":"1173968783","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1173968783","pubTimestamp":1772794696,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"LIVZON PHARMA (01513) has announced that its overseas wholly-owned subsidiary, LIANSGP HOLDING PTE. LTD. (LIANSGP), has formally received approval documents from the Vietnamese State Securities...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"161027":"证券","BK1191":"制药","01513":"丽珠医药"},"translate_title":"丽珠医药IMP股份要约收购获得越南监管机构批准","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"161027":1,"01513":1,"FVNmain":1},"content_text":"LIVZON PHARMA (01513) has announced that its overseas wholly-owned subsidiary, LIANSGP HOLDING PTE. LTD. (LIANSGP), has formally received approval documents from the Vietnamese State Securities Commission for its proposed public tender offer to acquire shares in IMP. The company's board of directors had previously approved the proposal to acquire equity in the Vietnamese company IMP and to launch a public tender offer for its shares during meetings held on May 22, 2025, and December 30, 2025. Following these board resolutions, LIANSGP submitted the relevant application for the tender offer to the Vietnamese regulatory authority. The company stated it will actively advance the matters related to this transaction.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"policyRegulatory","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1173968783","isCrawlerRequest":true}